Debevoise & Plimpton LLP

Debevoise & Plimpton LLP has a global cross-border practice, with particular expertise in handling M&A and transactional matters, complex litigation, IP litigation and white-collar investigations. Co-chair of the healthcare and life sciences group Andrew Bab assists with private acquisitions, divestitures and joint ventures, including cross-border transactions for both private equity and corporate clients. Fellow co-chair Mark Goodman frequently gives advice in high-risk matters involving the interplay of civil litigation, criminal liability and fiduciary obligations, while Maura Monaghan focuses on product liability, environmental, healthcare, criminal investigations and arbitration mandates. Based in Washington, DC, chair of the FDA regulatory practice Paul Rubin represents FDA-regulated drug, device and consumer product companies on a wide range of issues, ranging from strategic regulatory counseling to complex compliance and enforcement matters. All lawyers mentioned above are based in New York unless otherwise stated.